PolicyMIT Tech Review

When AI designs a drug, who gets the credit?

#ai#patents#biotechnology#intellectual property#innovation

English

The article discusses the challenges of patenting AI-designed drugs, highlighting that current laws only recognize humans as inventors. Despite AI's significant role in drug discovery, companies like Insilico Medicine still list human inventors on patents, raising questions about the future of intellectual property rights in the age of AI.

中文

本文讨论了AI设计药物在专利申请中的挑战，强调当前法律仅承认人类为发明者。尽管AI在药物发现中发挥了重要作用，但像Insilico Medicine这样的公司仍在专利上列出人类发明者，这引发了关于AI时代知识产权未来的问题。